Cargando…
Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760543/ https://www.ncbi.nlm.nih.gov/pubmed/30410082 http://dx.doi.org/10.1038/s41409-018-0383-2 |
| _version_ | 1783453886493753344 |
|---|---|
| author | Kim, Hee-Je Sohn, Hyun-Jung Hong, Jung-A Lee, Hyun-Joo Sohn, Dae-Hee Shin, Chang-Ae Cho, Hyun-Il Min, Woo-Sung Kim, Tai-Gyu |
| author_facet | Kim, Hee-Je Sohn, Hyun-Jung Hong, Jung-A Lee, Hyun-Joo Sohn, Dae-Hee Shin, Chang-Ae Cho, Hyun-Il Min, Woo-Sung Kim, Tai-Gyu |
| author_sort | Kim, Hee-Je |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6760543 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67605432019-09-26 Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial Kim, Hee-Je Sohn, Hyun-Jung Hong, Jung-A Lee, Hyun-Joo Sohn, Dae-Hee Shin, Chang-Ae Cho, Hyun-Il Min, Woo-Sung Kim, Tai-Gyu Bone Marrow Transplant Correspondence Nature Publishing Group UK 2018-11-08 2019 /pmc/articles/PMC6760543/ /pubmed/30410082 http://dx.doi.org/10.1038/s41409-018-0383-2 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Kim, Hee-Je Sohn, Hyun-Jung Hong, Jung-A Lee, Hyun-Joo Sohn, Dae-Hee Shin, Chang-Ae Cho, Hyun-Il Min, Woo-Sung Kim, Tai-Gyu Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial |
| title | Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial |
| title_full | Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial |
| title_fullStr | Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial |
| title_full_unstemmed | Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial |
| title_short | Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial |
| title_sort | post-transplant immunotherapy with wt1-specific ctls for high-risk acute myelogenous leukemia: a prospective clinical phase i/ii trial |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760543/ https://www.ncbi.nlm.nih.gov/pubmed/30410082 http://dx.doi.org/10.1038/s41409-018-0383-2 |
| work_keys_str_mv | AT kimheeje posttransplantimmunotherapywithwt1specificctlsforhighriskacutemyelogenousleukemiaaprospectiveclinicalphaseiiitrial AT sohnhyunjung posttransplantimmunotherapywithwt1specificctlsforhighriskacutemyelogenousleukemiaaprospectiveclinicalphaseiiitrial AT hongjunga posttransplantimmunotherapywithwt1specificctlsforhighriskacutemyelogenousleukemiaaprospectiveclinicalphaseiiitrial AT leehyunjoo posttransplantimmunotherapywithwt1specificctlsforhighriskacutemyelogenousleukemiaaprospectiveclinicalphaseiiitrial AT sohndaehee posttransplantimmunotherapywithwt1specificctlsforhighriskacutemyelogenousleukemiaaprospectiveclinicalphaseiiitrial AT shinchangae posttransplantimmunotherapywithwt1specificctlsforhighriskacutemyelogenousleukemiaaprospectiveclinicalphaseiiitrial AT chohyunil posttransplantimmunotherapywithwt1specificctlsforhighriskacutemyelogenousleukemiaaprospectiveclinicalphaseiiitrial AT minwoosung posttransplantimmunotherapywithwt1specificctlsforhighriskacutemyelogenousleukemiaaprospectiveclinicalphaseiiitrial AT kimtaigyu posttransplantimmunotherapywithwt1specificctlsforhighriskacutemyelogenousleukemiaaprospectiveclinicalphaseiiitrial |